METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
摘要
The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39hl-HPla silencing pathway for use in the treatment of a T- helper type 2 (Th2)-mediated disease, in particular allergic asthma.
申请公布号
WO2013050405(A1)
申请公布日期
2013.04.11
申请号
WO2012EP69514
申请日期
2012.10.03
申请人
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);INSTITUT CURIE
